PA2G4 was found to be highly expressed in cervical cancer, colon cancer, nasopharyngeal carcinoma and salivary adenoid cystic carcinoma [18–21], while it was found to be downregulated in HER2+ breast cancer [22] and bladder cancer [23]. The gene discussed is PA2G4; the disease is malignant colon neoplasm.